Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer

AIM: Tamoxifen (TAM) resistance remains a clinical issue in breast cancer. The authors previously reported that 15-hydroxyprostaglandin dehydrogenase (HPGD) was significantly downregulated in tamoxifen-resistant (TAMr) breast cancer cell lines. Here, the authors investigated the relationship between...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Explor Target Antitumor Ther
Prif Awduron: Volpato, Milene, Cummings, Michele, Shaaban, Abeer M., Abderrahman, Balkees, Hull, Mark A., Maximov, Philipp Y., Broom, Bradley M., Hoppe, Reiner, Fan, Ping, Brauch, Hiltrud, Jordan, V. Craig, Speirs, Valerie
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Open Exploration 2020
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7116369/
https://ncbi.nlm.nih.gov/pubmed/33210098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.37349/etat.2020.00021
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg